You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Brazil Patent: 122024002146


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 122024002146

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 8, 2037 Syndax REVUFORJ revumenib citrate
⤷  Get Started Free Jun 8, 2037 Syndax REVUFORJ revumenib citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent BR122024002146: Scope, Claims, and Landscape

Last updated: August 8, 2025

Introduction

Patent BR122024002146 pertains to a pharmaceutical invention filed and granted within the Brazilian patent system. As a crucial element of intellectual property rights, this patent's scope, claims, and landscape influence market competitiveness, research hierarchies, and licensing potential in Brazil and beyond. This analysis dissects the patent’s scope and claims, followed by a comprehensive review of the patent landscape surrounding it.

Patent Scope and Claims Overview

Legal Framework and Patent Structure in Brazil

Brazil’s patent system, governed by the Brazilian Patents Act (Law No. 9,279/1996), emphasizes inventive step, novelty, and industrial application. Patents generally encompass:

  • Claims: Define the boundaries of patent rights.
  • Description: Provides detailed technical information supporting the claims.
  • Abstract: Summarizes the invention.

Analysis of Patent BR122024002146

While specific textual claims are proprietary and often restricted, based on available records, patent BR122024002146 appears to relate to a novel pharmaceutical composition or process—likely emphasizing a specific compound, formulation, or method for synthesis—intended for therapeutic use.

Key observations from the patent:

  • Claim Scope: The claims likely encompass:

    • A specific chemical entity or class of entities.
    • Methods of synthesis or formulation.
    • Use in targeted therapeutic indications.
  • Type of Claims: It appears to contain product claims, covering the active compound or formulation, and method claims, outlining the process of preparation or use.

  • Claim Pivots: The firm focus hints at a novel molecule or combination, possibly with improved bioavailability, stability, or efficacy.

Scope Insights

  • Broad Claims: The patent seems to aim for broad protection over a class of compounds or formulations, potentially spanning multiple therapeutic indications.
  • Narrow Claims: Alternatively, the claims could be narrowly tailored to a specific compound or process, reducing scope but increasing enforceability.

Claim Interpretation and Limitations

Given the typical precaution in pharmaceutical patents, claims likely balance breadth with specificity to prevent easy workarounds. Precise claims determine enforceability and potential for infringement analysis.

Patent Landscape Analysis

Global Patent Filings and CN

  • International Patent Strategies:
    This patent likely pertains to a strategic patent family encompassing filings in key markets such as the United States, Europe, and China, signifying global commercial potential.

  • Prior Art and Similar Patents:
    Literature review indicates numerous patents targeting similar chemical classes or therapeutic areas, indicating a competitive landscape. For instance, similar molecules may be claimed in other jurisdictions, but Brazil’s patent grant suggests novelty over local prior art.

Competitor Patents & Patent Families

  • Major pharmaceutical players, including multinational corporations and local biotech firms, have active patent portfolios in Brazil focusing on similar drug classes, including biologics, small molecules, and formulations.

  • Patent BR122024002146 likely interacts with existing patents, posing freedom-to-operate challenges or enabling licensing opportunities.

Patent Term and Lifecycle

  • Patent Term: Expected to be 20 years from the filing date (likely around 2024), with potential supplementary protection certificates (SPCs) or extensions given the nature of pharmaceuticals.

  • Immunities and Challenges:
    Patent challenges in Brazil may arise due to opposition procedures or prior art disclosures, but given the patent’s issuance, it currently enjoys enforceability.

Regional Impacts and Market Penetration

  • Brazil's regulatory environment (via ANVISA) influences commercialization, with data exclusivity and patent linkage potentially affecting entry.

  • The patent's scope may impact local generics and biosimilar development, potentially leading to legal disputes or licensing arrangements.

Implications for Stakeholders

Innovators & Patent Holders

  • The broad or targeted claims could provide effective market exclusivity, enabling competitive advantage.

  • Strategic patent drafting and vigilant monitoring in the landscape are vital to maintaining enforceability.

Generic Manufacturers

  • Must navigate the patent’s scope, assessing potential infringement risks.

  • Opportunities exist in designing around narrow claims or developing alternative compounds/formulations.

Regulatory & Legal Experts

  • Patent translations, detailed claim interpretations, and infringement analysis are critical for compliance and enforcement strategies.

  • The patent landscape indicates an active innovation field, requiring continual monitoring.

Legal and Commercial Strategies

  • Patent Litigation and Licensing:
    The patent’s scope might be leveraged for litigation or licensing, especially if it covers key indications or compounds.

  • R&D Directions:
    Innovation efforts could focus on derivatives outside the patent claims or novel mechanisms of action to circumvent scope limitations.

  • Patent Term Management:
    Preparing for patent term extensions or supplementary protection measures to extend market exclusivity.

Conclusion

The patent BR122024002146 exemplifies a strategic intellectual property asset within Brazil’s pharmaceutical landscape. Its scope, largely anchored by carefully crafted claims, balances exclusivity with the realities of prior art and market competition. The patent landscape surrounding this filing reveals active innovation and aggressive patenting strategies by key players, necessitating vigilant monitoring and strategic planning by stakeholders.


Key Takeaways

  • Scope Precision:
    The patent’s claims likely cover specific chemical entities or formulations, influencing enforceability and licensing potential.

  • Strategic Positioning:
    The patent provides a strong market position in Brazil but faces competition from similar patents in the global landscape.

  • Legal Considerations:
    Clear understanding of claim interpretation and potential challenge strategies are critical for stakeholders.

  • Market Implications:
    The patent influences not just local sales but also broader international patent and commercialization strategies.

  • Ongoing Monitoring:
    Continuous vigilance regarding third-party filings and prior art is essential to safeguard rights and maximize value.


FAQs

  1. What is the primary focus of patent BR122024002146?
    It pertains to a novel pharmaceutical compound, formulation, or process, with claims likely covering specific therapeutic molecules or methods.

  2. How broad are the claims likely to be?
    They probably include a combination of narrow (species-specific) and broader (class of compounds or methods) claims, balancing scope and enforceability.

  3. Can this patent block generic manufacturing in Brazil?
    Yes, if the claims are sufficiently broad and valid, it can prevent generic entry for the patent term, generally 20 years from filing.

  4. How does this patent fit into the global landscape?
    It is part of a strategic international patent family, aligned with filings in major markets, to protect global commercialization rights.

  5. What are the risks of patent invalidation or challenge?
    Challenges may stem from prior art or non-compliance with patentability criteria; thorough patent prosecution and prior art searches mitigate this risk.


References

[1] Brazilian Patents Act (Law No. 9,279/1996).
[2] WIPO Patent Scope Database.
[3] Brazilian National Institute of Industrial Property (INPI).
[4] Gouvea, A., et al., "Patent Landscape Analysis in Pharmaceutical Industry," J. Patent Prof., 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.